Catherine studied anatomical science at the University of Bristol before heading to London. She completed her PhD in Immunology at Barts and the London School of Medicine and Dentistry, tracking the movement of immune cells. She joined the Science Communications team at Cancer Research UK in 2016, where she works to help communicate the charity’s research to the public.
We spoke with Professor Kev Dhaliwal, chief investigator of the SPIKE-1 trial, about how repurposing a drug in a COVID-19 trial could benefit people with cancer.
Trial finds prostate radiotherapy plus standard treatment improves survival for some men whose prostate cancer has spread, which could help thousands in the UK.
We look at why researchers are working towards brain tumour treatments that are not only more effective, but also kinder.
Headlines from last year could have you believe that eating oranges could cure cancer. But is there any evidence behind vitamin C as a cancer treatment?
Find out the burning questions some of our researchers want to answer as they set up their own research teams for the first time.
We’d like to introduce the latest bunch of scientists that we’ve given funding to head up their own research teams for the first time.
Drawing similarities between how the immune system reacts to lung cancer and HIV could uncover potential new drug targets.
Frozen needles, a smokefree UK, microbubbles and how scientists in the US are trying to break cancer cells’ ‘legs’. Here’s our weekly news report.
Improving prostate cancer survival, a life-extending app, yoga and our tribute to the remarkable Professor Patrick Johnston. Here’s our weekly news report.